Neuberger Berman High Yield Strategies Fund Inc. (NYSE: NHS) is a closed-end fixed income mutual fund that seeks high total return through income and capital appreciation by investing at least 80% of its total assets in high yield debt securities of U.S. and foreign issuers under normal market conditions. The fund primarily targets high yield bonds across various sectors including auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated services, gaming, and gas distribution; it employs active management focused on value-oriented selection, risk assessment, and portfolio adjustments to generate stable monthly distributions comprising net investment income, realized capital gains, and return of capital. Launched by Neuberger Berman LLC and managed by Neuberger Berman Investment Advisers LLC, the fund was formed on July 28, 2003, and is domiciled in the United States with principal executive offices at 1290 Avenue of the Americas, New York, New York 10104.
The fund operates within the asset management industry, serving income-seeking investors through its closed-end structure traded on the NYSE American exchange, with a focus on global fixed income markets and high yield segments characterized by credit quality risks and leverage considerations.
In recent developments, the fund announced changes to its portfolio management team on December 15, 2025, with Joseph Lind and Christopher Kocinski serving as current portfolio managers following prior transitions including the unexpected passing of co-portfolio manager Patrick Flynn earlier in 2025; it maintains a level distribution policy with monthly payouts of $0.0905 per share, as reaffirmed in its November 2025 announcement, amid ongoing market challenges related to yield sustainability and high leverage costs.